Compound Researcher

Our public theses

We just published our second monthly newsletter highlighting our latest research, events, and must reads If you haven't already, subscribe at the link below!

Last month, @CompoundVC launched a monthly newsletter that includes our latest research, theses, events, and must reads Sign up at the link below!

Truly inspiring glimpse at faster, cheaper and even multiplexed in vivo evidence As asset generation commodifies & preclinical timelines trend to zero, this becomes even more of the key bottleneck to biomedical progress - Manifold & Gordian: massively multiplexed in vivo animal screening technologies - Sid Sijbrandij: going founder mode on his cancer and the companies he's creating to help others do the same - Presage: multiplexed Phase 0s to get human efficacy + MoA data on many drugs per cancer patient without IND or GMP - Pheiron: aggregates national scale multimodal biobank data to predict clinical outcomes - hVIVO: largest operator of human challenge trials for infectious diseases - Metabolis: running often decentralized trials to test nutraceuticals/food as medicine for rare or n-of-1 metabolic diseases - Medable: tech to run clinical ops more efficiently If you're exploring building in this space, it's never too early to talk with us! Thank you to @shelbynewsad for doing the hard work, to the speakers, audience, and SVB! @sytses @glebkuz @MartinBJensen @PresageBio @hVIVO_UK @SteinfeldtJakob @eperlste @medableinc

Using prediction markets and forecasting surveys to predict 28 replication outcomes of classic articles in social psychology and judgement and decision making royalsocietypublishing.org/rsos/article/1…

New Post: The Fickleness of Scaling Laws Nothing has defined tech in the last 5yrs. "Bigger = better" was applied to every field possible But very few other teams in any other field has demonstrated them. And almost no one actually knows what drives them and their preconditions